Skip to main content
XCUR logo

Exicure, Inc.

XCURNASDAQHealthcareBiotechnology

$1.09Today:- (-)1Y −76.16%

As of Oct 26, 2026 close

Market cap
$6.95M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.94$9.48
Volume (live)
-
Avg. volume (3M)
47.64K

Exicure (XCUR) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Exicure used $8.55M of cash in operating activities and spent $1.00K on capital expenditures. That left free cash flow of −$8.56M.

Exicure Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Exicure, Inc. (XCUR) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income-4.95-9.70-16.91-2.58-64.10-24.67-26.30-22.41-11.01
Depreciation & Amortization0.460.031.381.861.781.450.720.360.23
Deferred Income Tax-0.630.000.000.000.00-0.08-0.390.27-0.21
Stock Based Compensation0.000.021.351.372.942.181.841.811.46
Change in Working Capital1.140.630.91-36.8224.11-18.3325.21-0.01-10.45
Change in Accounts Receivable1.34-0.510.000.000.010.02-0.030.01-0.01
Change in Inventory0.000.000.000.000.00-2.23-0.370.78-2.35
Change in Accounts Payable0.18-0.191.27-3.051.580.360.79-0.560.20
Change in Other Working Capital-0.380.15-0.360.520.29-16.4924.83-0.24-10.63
Other Operating Activities-4.586.112.920.520.290.180.230.50-0.03
Net Cash from Operating Activities-8.56-2.91-10.36-35.66-34.82-39.271.32-19.49-19.79
Investing Activities
Capital Expenditures0.000.000.00-0.01-0.97-3.17-1.08-0.09-0.93
Acquisitions-1.810.000.000.000.003.170.000.000.00
Purchases of Investments0.000.00-2.00-1.50-6.50-56.64-62.350.000.00
Sales/Maturities of Investments0.000.000.006.0050.5569.950.000.000.00
Other Investing Activities0.000.000.920.210.00-3.170.000.000.00
Net Cash from Investing Activities-1.810.00-1.084.7043.0910.14-63.43-0.09-0.93
Financing Activities
Debt Repayment0.001.000.00-7.50-10.0012.500.000.00-1.00
Common Stock Issued1.6012.405.445.0411.482.9790.7522.0031.51
Common Stock Repurchased0.000.000.000.00-0.010.000.000.000.00
Other Financing Activities0.000.00-0.97-0.66-1.13-0.34-6.44-1.92-3.66
Net Cash from Financing Activities1.6013.403.67-3.111.1215.1384.3120.0926.86
Summary
Net Change in Cash-8.7610.49-7.76-34.079.38-14.0022.190.506.14
Cash at Beginning of Period12.512.029.7843.8434.4648.4626.2725.7619.62
Cash at End of Period3.7512.512.029.7843.8434.4648.4626.2725.76
Free Cash Flow-8.56-2.91-10.36-35.67-35.79-42.440.24-19.58-20.72
Supplemental Disclosures
Interest Paid---0.191.380.39---

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Exicure Cash Flow

What is Exicure's free cash flow?

Exicure had negative free cash flow of $8.56M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$8.55M minus $1.00K of capital expenditures.

How much does Exicure spend on capital expenditures?

Exicure spent $1.00K on capital expenditures in fiscal 2025.

Does Exicure pay dividends or buy back shares?

Exicure's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition